학술논문
KB001-A, a novel anti-inflammatory, found to be safe and well-tolerated in cystic fibrosis patients infected with Pseudomonas aeruginosa
Document Type
Article
Author
Source
In Journal of Cystic Fibrosis July 2018 17(4):484-491
Subject
Language
ISSN
1569-1993